Cevimeline Hydrochloride

Product NDC
72162-2563
11-digit product format
721622563
Labeler code
72162
Product ID
72162-2563_fb360aef-a237-424f-95a0-f39d33113bd7
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Cevimeline Hydrochloride
Dosage form
CAPSULE
Route
ORAL
Labeler
Bryant Ranch Prepack
Application
ANDA215056
Marketing category
ANDA
Marketing start
2023-04-18
Substance
CEVIMELINE HYDROCHLORIDE
Active strength
30 mg/1
Pharmacologic classes
Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A215056-001CEVIMELINE HYDROCHLORIDECEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2023-04-18

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A215056-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A215056-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2023-04-1884e616aacf4f…
2026-08-18 06:07:402026-07A215056-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2023-04-18caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A215056-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2023-04-18011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A215056-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2023-04-1831067a03dcf5…
2025-08-23 18:47 UTC2025-08A215056-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2023-04-186a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A215056-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2023-04-18fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A215056-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2023-04-18b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A215056-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2023-04-1803ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A215056-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2023-04-182680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A215056-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2023-04-185bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A215056-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2023-04-18d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A215056-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2023-04-18d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A215056-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2023-04-1879d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A215056-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2023-04-18301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A215056-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2023-04-181e350fbaab3a…
2024-05-31 18:47 UTC2024-05A215056-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2023-04-188072bd15b7f6…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A215056-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2023-04-186a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A215056-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2023-04-181c564ffb4f44…
2023-12-20 04:57 UTC2023-12A215056-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2023-04-18ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A215056-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2023-04-18a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A215056-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2023-04-189b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A215056-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2023-04-18a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A215056-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2023-04-183f0d92c62455…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A215056-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2023-04-18a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A215056-001AB184e616aacf4f…
2026-08-18 06:07:402026-07A215056-001AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A215056-001AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A215056-001AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A215056-001AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A215056-001AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A215056-001AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A215056-001AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A215056-001AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A215056-001AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A215056-001AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A215056-001AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A215056-001AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A215056-001AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A215056-001AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A215056-001AB18072bd15b7f6…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A215056-001AB16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A215056-001AB11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A215056-001AB1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A215056-001AB1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A215056-001AB19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A215056-001AB1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A215056-001AB13f0d92c62455…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A215056-001AB1a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Cevimeline Hydrochloride
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
CEVIMELINE HYDROCHLORIDE30 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
P81Q6V85NPInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
309140Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
71ada1b0-3344-4202-9277-57f1a37402c1Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
5ee6cfc6-9666-4038-bf74-eee52d7e4a72Product name420250331

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72162-2563-1Cevimeline Hydrochloride100 in 1 BOTTLECAPSULE100100

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
72162-2563-1EA - Each72162-25631dc70e67-0a46-423e-8881-914ca2233a0312025-12-16

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Cevimeline HydrochlorideCEVIMELINE HYDROCHLORIDEBryant Ranch Prepack71ada1b0-3344-4202-9277-57f1a37402c12025-11-04Warnings, Adverse reactionsExact identifier
application applno (ANDA): 215056
application number: ANDA215056
ndc (product): 72162-2563
Cevimeline HydrochlorideCEVIMELINE HYDROCHLORIDEAurobindo Pharma Limitedd08d8aa5-76a4-417a-a308-7d195865522f2023-04-19Warnings, Adverse reactionsExact identifier
application applno (ANDA): 215056
application number: ANDA215056

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
309140cevimeline HCl 30 MG Oral CapsulePSN71ada1b0-3344-4202-9277-57f1a37402c1100
309140cevimeline hydrochloride 30 MG Oral CapsuleSCD71ada1b0-3344-4202-9277-57f1a37402c1100

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
72162-2563-172162256301100 CAPSULE in 1 BOTTLE (72162-2563-1) 100 capsule2025-11-04NoNoCurrent